Akebia Therapeutics (AKBA) Ownership - Who Owns Akebia Therapeutics?

1,643 Followers

Akebia Therapeutics (AKBA) Ownership Overview

2.85% Insiders

8.74% Mutual Funds

2.73% Other Institutional Investors

12.87% ETFs

72.81% Public Companies and

Individual Investors

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 24.34% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 72.81% is owned by Public Companies and Individual Investors.

The ownership structure of Akebia Therapeutics (AKBA) stock is a mix of institutional, retail, and individual investors. Approximately 11.48% of the company’s stock is owned by Institutional Investors, 2.85% is owned by Insiders, and 12.87% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 05, 2026	John P. Butler	xxxxxxxxxxxxx	$86588

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Royce & Associates Llc	xxxxxxxxxxxxx	$39438
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$345209
Dec 31, 2023	Entrypoint Capital, Llc	xxxxxxxxxxxxx	$280431

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
13,161,555	Institution	4.91%	12,306,054
10,892,584	Institution	4.06%	10,184,566
9,778,980	Institution	3.65%	9,143,346
7,089,674	Institution	2.64%	6,628,845
3,526,992	Insider	1.31%	3,297,738
2,786,054	Institution	1.04%	2,604,960
2,623,743	Institution	0.98%	2,453,200
1,460,430	Institution	0.54%	1,365,502
1,265,099	Institution	0.47%	1,182,868
1,261,474	Institution	0.47%	1,179,478

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
10,892,584	Institution	4.06%	10,184,566
2,786,054	Institution	1.04%	2,604,960
2,623,743	Institution	0.98%	2,453,200
1,460,430	Institution	0.54%	1,365,502
757,990	Institution	0.28%	708,721
746,039	Institution	0.28%	697,546
534,187	Institution	0.20%	499,465
501,389	Institution	0.19%	468,799
396,648	Institution	0.15%	370,866
377,940	Institution	0.14%	353,374

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	7,912,283	Institution	2.95%	10,918,951
SPDR S&P BIOTECH ETF	6,667,093	Institution	2.49%	6,469,080
iShares Russell 2000 ETF	5,916,753	Institution	2.21%	5,533,939
Vanguard Extended Market ETF	3,001,615	Institution	1.12%	4,142,229
iShares Russell 2000 Value ETF	1,981,304	Institution	0.74%	1,853,114
Vanguard Russell 2000 ETF	1,277,250	Institution	0.48%	1,762,605
Schwab U.S. Small-Cap ETF	1,265,099	Institution	0.47%	1,227,526
Fidelity Enhanced Small Cap ETF	1,261,333	Institution	0.47%	1,223,871
Vanguard Health Care ETF	752,167	Institution	0.28%	1,037,990
iShares Micro-Cap ETF	647,816	Institution	0.24%	605,902

FAQ

Who Owns Akebia Therapeutics (AKBA)?

According to the latest TipRanks data, approximately 2.73% of the company's stock is held by institutional investors, 2.85% is held by insiders, and 72.81% is held by retail investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by institutional investors?

According to the latest TipRanks data, approximately 2.73% of Akebia Therapeutics (AKBA) stock is held by institutional investors.

What percentage of Akebia Therapeutics (AKBA) stock is held by retail investors?

According to the latest TipRanks data, approximately 72.81% of Akebia Therapeutics (AKBA) stock is held by retail investors.

Who owns the most shares of Akebia Therapeutics (AKBA)?

Vanguard owns the most shares of Akebia Therapeutics (AKBA).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.